View in EDS HTML Full Text PDF Full Text

Solid amorphous formulations for enhancing solubility and inhibiting Erlotinib crystallization during gastric-to-intestinal transfer.

Saved in:
Bibliographic Details
Title: Solid amorphous formulations for enhancing solubility and inhibiting Erlotinib crystallization during gastric-to-intestinal transfer.
Authors: Mugnier, L.1 (AUTHOR), Espitalier, F.1 (AUTHOR), Menegotto, J.2 (AUTHOR), Bell, S.3 (AUTHOR), Ré, M. I.1 (AUTHOR)
Source: Pharmaceutical Development & Technology. Sep2023, Vol. 28 Issue 7, p697-707. 11p.
Database: Business Source Ultimate
Full text is not displayed to guests.
Description
ISSN:10837450
DOI:10.1080/10837450.2023.2233612